2023-2029 Global Pharmaceutical CRDMO Service Industry Research & Trends Analysis Report
Report Code: KNJ1623517 No. of Pages: 146 Category: Services
Publisher: Date of Publish:
Publisher: Date of Publish:
According to YH Research, the global market for Pharmaceutical CRDMO Service should grow from US$ 83 million in 2022 to US$ 130.6 million by 2029, with a CAGR of 6.8% for the period of 2023-2029.
China Pharmaceutical CRDMO Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Pharmaceutical CRDMO Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Small Molecule CRDMO Service segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Oncology has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Pharmaceutical CRDMO Service include BioDuro-Sundia, Sai Life Sciences, Icosagen, WuXi Biologics, WuXi AppTec, Esco Aster, Jubilant Biosys, Syngene International and Chemveda, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Pharmaceutical CRDMO Service. Report Highlights:
(1) Global Pharmaceutical CRDMO Service market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Pharmaceutical CRDMO Service market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Pharmaceutical CRDMO Service market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Pharmaceutical CRDMO Service segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Pharmaceutical CRDMO Service segment by type and by application and regional segment by type and by application.
(6) Pharmaceutical CRDMO Service industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Small Molecule CRDMO Service
Middle Molecule CRDMO Service
Large Molecule CRDMO Service
Market segment by application, can be divided into
Oncology
Infectious Disease
Neurology
Immunology
Hematology
Vaccine
Others
Market segment by players, this report covers
BioDuro-Sundia
Sai Life Sciences
Icosagen
WuXi Biologics
WuXi AppTec
Esco Aster
Jubilant Biosys
Syngene International
Chemveda
Ardena Holding
Eurofins
Jiangsu HUAYI Technology Co., Ltd.
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical CRDMO Service
1.2 Global Pharmaceutical CRDMO Service Market Size and Forecast
1.3 China Pharmaceutical CRDMO Service Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Pharmaceutical CRDMO Service Share in Global Market, 2018-2029
1.4.2 Pharmaceutical CRDMO Service Market Size: China VS Global, 2018-2029
1.5 Pharmaceutical CRDMO Service Market Dynamics
1.5.1 Pharmaceutical CRDMO Service Market Drivers
1.5.2 Pharmaceutical CRDMO Service Market Restraints
1.5.3 Pharmaceutical CRDMO Service Industry Trends
1.5.4 Pharmaceutical CRDMO Service Industry Policy
2 Global Competitive Situation by Company
2.1 Global Pharmaceutical CRDMO Service Revenue by Company (2018-2023)
2.2 Global Pharmaceutical CRDMO Service Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Pharmaceutical CRDMO Service Concentration Ratio
2.4 Global Pharmaceutical CRDMO Service Mergers & Acquisitions, Expansion Plans
2.5 Global Pharmaceutical CRDMO Service Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Pharmaceutical CRDMO Service Revenue by Company (2018-2023)
3.2 China Pharmaceutical CRDMO Service Pharmaceutical CRDMO Service Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Pharmaceutical CRDMO Service, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Pharmaceutical CRDMO Service Industry Chain
4.2 Pharmaceutical CRDMO Service Upstream Analysis
4.3 Pharmaceutical CRDMO Service Midstream Analysis
4.4 Pharmaceutical CRDMO Service Downstream Analysis
5 Sights by Type
5.1 Pharmaceutical CRDMO Service Classification
5.1.1 Small Molecule CRDMO Service
5.1.2 Middle Molecule CRDMO Service
5.1.3 Large Molecule CRDMO Service
5.2 By Type, Global Pharmaceutical CRDMO Service Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Pharmaceutical CRDMO Service Revenue, 2018-2029
6 Sights by Application
6.1 Pharmaceutical CRDMO Service Segment by Application
6.1.1 Oncology
6.1.2 Infectious Disease
6.1.3 Neurology
6.1.4 Immunology
6.1.5 Hematology
6.1.6 Vaccine
6.1.7 Others
6.2 By Application, Global Pharmaceutical CRDMO Service Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Pharmaceutical CRDMO Service Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Pharmaceutical CRDMO Service Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Pharmaceutical CRDMO Service Market Size, 2018-2029
7.3 North America
7.3.1 North America Pharmaceutical CRDMO Service Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Pharmaceutical CRDMO Service Market Size Market Share
7.4 Europe
7.4.1 Europe Pharmaceutical CRDMO Service Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Pharmaceutical CRDMO Service Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Pharmaceutical CRDMO Service Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Pharmaceutical CRDMO Service Market Size Market Share
7.6 South America
7.6.1 South America Pharmaceutical CRDMO Service Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Pharmaceutical CRDMO Service Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Pharmaceutical CRDMO Service Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Pharmaceutical CRDMO Service Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Pharmaceutical CRDMO Service Market Size, 2018-2029
8.3.2 By Company, U.S. Pharmaceutical CRDMO Service Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Pharmaceutical CRDMO Service Market Size, 2018-2029
8.4.2 By Company, Europe Pharmaceutical CRDMO Service Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Pharmaceutical CRDMO Service Market Size, 2018-2029
8.5.2 By Company, China Pharmaceutical CRDMO Service Revenue Market Share, 2018-2023
8.5.3 By Type, China Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Pharmaceutical CRDMO Service Market Size, 2018-2029
8.6.2 By Company, Japan Pharmaceutical CRDMO Service Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Pharmaceutical CRDMO Service Market Size, 2018-2029
8.7.2 By Company, South Korea Pharmaceutical CRDMO Service Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Pharmaceutical CRDMO Service Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Pharmaceutical CRDMO Service Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Pharmaceutical CRDMO Service Market Size, 2018-2029
8.9.2 By Company, India Pharmaceutical CRDMO Service Revenue Market Share, 2018-2023
8.9.3 By Type, India Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Pharmaceutical CRDMO Service Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Pharmaceutical CRDMO Service Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Pharmaceutical CRDMO Service Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 BioDuro-Sundia
9.1.1 BioDuro-Sundia Company Information, Head Office, Market Area and Industry Position
9.1.2 BioDuro-Sundia Company Profile and Main Business
9.1.3 BioDuro-Sundia Pharmaceutical CRDMO Service Models, Specifications and Application
9.1.4 BioDuro-Sundia Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.1.5 BioDuro-Sundia Recent Developments
9.2 Sai Life Sciences
9.2.1 Sai Life Sciences Company Information, Head Office, Market Area and Industry Position
9.2.2 Sai Life Sciences Company Profile and Main Business
9.2.3 Sai Life Sciences Pharmaceutical CRDMO Service Models, Specifications and Application
9.2.4 Sai Life Sciences Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.2.5 Sai Life Sciences Recent Developments
9.3 Icosagen
9.3.1 Icosagen Company Information, Head Office, Market Area and Industry Position
9.3.2 Icosagen Company Profile and Main Business
9.3.3 Icosagen Pharmaceutical CRDMO Service Models, Specifications and Application
9.3.4 Icosagen Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.3.5 Icosagen Recent Developments
9.4 WuXi Biologics
9.4.1 WuXi Biologics Company Information, Head Office, Market Area and Industry Position
9.4.2 WuXi Biologics Company Profile and Main Business
9.4.3 WuXi Biologics Pharmaceutical CRDMO Service Models, Specifications and Application
9.4.4 WuXi Biologics Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.4.5 WuXi Biologics Recent Developments
9.5 WuXi AppTec
9.5.1 WuXi AppTec Company Information, Head Office, Market Area and Industry Position
9.5.2 WuXi AppTec Company Profile and Main Business
9.5.3 WuXi AppTec Pharmaceutical CRDMO Service Models, Specifications and Application
9.5.4 WuXi AppTec Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.5.5 WuXi AppTec Recent Developments
9.6 Esco Aster
9.6.1 Esco Aster Company Information, Head Office, Market Area and Industry Position
9.6.2 Esco Aster Company Profile and Main Business
9.6.3 Esco Aster Pharmaceutical CRDMO Service Models, Specifications and Application
9.6.4 Esco Aster Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.6.5 Esco Aster Recent Developments
9.7 Jubilant Biosys
9.7.1 Jubilant Biosys Company Information, Head Office, Market Area and Industry Position
9.7.2 Jubilant Biosys Company Profile and Main Business
9.7.3 Jubilant Biosys Pharmaceutical CRDMO Service Models, Specifications and Application
9.7.4 Jubilant Biosys Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.7.5 Jubilant Biosys Recent Developments
9.8 Syngene International
9.8.1 Syngene International Company Information, Head Office, Market Area and Industry Position
9.8.2 Syngene International Company Profile and Main Business
9.8.3 Syngene International Pharmaceutical CRDMO Service Models, Specifications and Application
9.8.4 Syngene International Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.8.5 Syngene International Recent Developments
9.9 Chemveda
9.9.1 Chemveda Company Information, Head Office, Market Area and Industry Position
9.9.2 Chemveda Company Profile and Main Business
9.9.3 Chemveda Pharmaceutical CRDMO Service Models, Specifications and Application
9.9.4 Chemveda Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.9.5 Chemveda Recent Developments
9.10 Ardena Holding
9.10.1 Ardena Holding Company Information, Head Office, Market Area and Industry Position
9.10.2 Ardena Holding Company Profile and Main Business
9.10.3 Ardena Holding Pharmaceutical CRDMO Service Models, Specifications and Application
9.10.4 Ardena Holding Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.10.5 Ardena Holding Recent Developments
9.11 Eurofins
9.11.1 Eurofins Company Information, Head Office, Market Area and Industry Position
9.11.2 Eurofins Company Profile and Main Business
9.11.3 Eurofins Pharmaceutical CRDMO Service Models, Specifications and Application
9.11.4 Eurofins Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.11.5 Eurofins Recent Developments
9.12 Jiangsu HUAYI Technology Co., Ltd.
9.12.1 Jiangsu HUAYI Technology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
9.12.2 Jiangsu HUAYI Technology Co., Ltd. Company Profile and Main Business
9.12.3 Jiangsu HUAYI Technology Co., Ltd. Pharmaceutical CRDMO Service Models, Specifications and Application
9.12.4 Jiangsu HUAYI Technology Co., Ltd. Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.12.5 Jiangsu HUAYI Technology Co., Ltd. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com